Chicago Capital Management’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-141,111
Closed -$3.95M 41
2022
Q1
$3.95M Buy
+141,111
New +$3.87M 2.25% 17

Chicago Capital Management's XENT Position: Q2 2022 in Review

Chicago Capital Management sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 141,111 shares — an estimated $3.95M sold.

Chicago Capital Management first reported a position in XENT in Q1 2022 and held it in 1 quarter. The position peaked at $3.95M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Chicago Capital Management reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Chicago Capital Management sold 141,111 Intersect ENT, Inc shares in Q2 2022, an estimated $3.95M.
  • Chicago Capital Management first reported a position in Intersect ENT, Inc in Q1 2022 and held it in 1 quarter.
  • Chicago Capital Management's Intersect ENT, Inc position peaked at $3.95M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Chicago Capital Management's 13F filing for Q2 2022, filed 27 Jul 2022.